Navigation Links
Echo Therapeutics Announces Management Changes
Date:8/26/2013

PHILADELPHIA, Aug. 26, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its non-invasive Symphony® CGM System as a needle-free, wireless continuous glucose monitoring system, today announced that its Chief Executive Officer, President and Chairman of the Board, Dr. Patrick Mooney, is taking an immediate leave of absence.  Robert Doman, a member of Echo's Board of Directors, will serve as Executive Chairman and Interim Chief Executive Officer. 

Mr. Doman has over 30 years of executive level, international and domestic management, business development, sales and marketing, product development and strategic planning experience with specific concentrations in medical devices and pharmaceuticals.  Most recently, Mr. Doman served as President and Chief Executive Officer of publicly-traded DUSA Pharmaceuticals, Inc., which was successfully sold to Sun Pharmaceuticals in a $230 million transaction in 2012. 

Effective immediately, William Grieco, Chairman of the Company's Nominating and Corporate Governance Committee and a member of Echo's Board since February 2011, has been appointed Lead Independent Director of the Board. 

"Echo's business operations will continue as usual in Dr. Mooney's absence," said Mr. Doman.  "We remain focused on completing our ongoing clinical studies and filing the Symphony CGM System technical file for CE Marking in the near future."

The Board of Directors will be engaging an executive search firm to assist it in identifying a new CEO.  Mr. Grieco commented, "We're extremely fortunate to have Bob serving as Executive Chairman and Interim CEO at this critically important juncture for the Company." 

About Echo Therapeutics

Echo Therapeutics
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. aTyr Pharma Awarded Two Patents from USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
2. aTyr Pharma Expands Executive Leadership Team to Support Development of New Therapeutics Based on Physiocrine Biology
3. Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech
4. PTC Therapeutics Reports Second Quarter 2013 Financial and Corporate Results
5. Aratana Therapeutics Reports Second Quarter 2013 Financial Results
6. Breckenridge Enters Into Agreement to Acquire Certain Cypress Assets from Pernix Therapeutics
7. Northwest Biotherapeutics Announces Registered Direct Offering
8. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
9. Echo Therapeutics Announces Second Quarter 2013 Financial Results
10. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
11. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Cynosure, Inc. (NASDAQ: ... for non-invasive and minimally invasive applications, today announced that the ... Officer and Chief Financial Officer Timothy W. Baker ... 53, will continue to serve as CFO and will take ... remains Chairman and Chief Executive Officer. "Tim ...
(Date:7/30/2014)... -- Packaging Coordinators, Inc. (PCI) is pleased to announce it ... Services Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... United Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug ... form manufacturing, as well as Clinical Packaging, Labeling, and ...
(Date:7/30/2014)... MIAMI , July 30, 2014   Medical ... they have been awarded a Department of Defense (US ... months to supply a mobile MRI diagnostic machine and ... Small Business (WOSB) through the Small Business Administration (SBA), ... in the field with the latest medical diagnostic equipment. ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... Inc. today announced publication of results from a pivotal ... the treatment of breakthrough cancer pain (BTCP). The article, ... Pectin Nasal Spray (FPNS) in the treatment of breakthrough ... the peer-reviewed journal from the International Association for the ...
... October 4, 2010 ... ... var shortURL ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = ...
Cached Medicine Technology:Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain 2Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain 335th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 235th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 335th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 435th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 535th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 635th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 735th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 835th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 935th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 1035th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 1135th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 12
(Date:7/30/2014)... The Dr. Hector P. Garcia Memorial Foundation, ... proposed naming of the new primary care facility in ... Health Center. , The proposed 40,000 sq. ft. facility ... chronic disease management programs, pharmacy services and wellness and ... home model center. , Dr. Hector P. Garcia, for ...
(Date:7/30/2014)... July 30, 2014 Decene is ... a chain of ten carbon atoms with one ... typical of 1-decenes. It can be used as ... intermediate to produce epoxides, amines, oxo alcohols, synthetic ... , Early buyers will receive 10% customization on ...
(Date:7/30/2014)... -- Medical costs for chronic obstructive pulmonary disease (COPD) ... each year, according to new research from the U.S. ... financial toll of COPD (which includes emphysema and chronic ... by 2020. "For the first time, our analyses ... health practitioners with estimates of the economic burden of ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 The global digital ... 2013 and is expected to grow at a CAGR of ... The demand for digital pathology is growing and is expected ... The use of scanners and image analysis software enable pathologists ... for patients. , In 2013, the North American market was ...
(Date:7/30/2014)... Los Angeles, CA (July 30, 2014) With the ... has become a popular science and researchers must ... in the study of stroke rehabilitation. A new ... discusses a systematic shift in perspective and suggests ... brain would strongly promote stroke motor recovery, for ...
Breaking Medicine News(10 mins):Health News:Dr. Hector P Garcia Memorial Foundation Supports New Health Care Facility 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Annual COPD Costs To Hit $49 Billion by 2020: CDC 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5Health News:Neuro researchers advocate for a shift in thinking for stroke rehabilitation 2
... Rare Diseases, BETHESDA, Md., April 24 ... of Representatives for passing,legislation to reauthorize the Small ... testimony from Robert J. Beall, Ph.D., president and ... requiring that,special attention be given to research for ...
... The following are,excerpts from an article in The ... Republican National Committee:, Congressional Democrats are backing away ... saying that even if,their party controls the White House ... some senators, the promises made by Sens. Barack Obama ...
... (Nasdaq: ONXX ) today announced that it ... Conference on Thursday,May 1, at 8:00 a.m. Eastern ... of the presentation on our website at:, ... listeners log on 15 minutes early in order ...
... how brain cell communication may be altered in schizophrenia ... at the Medical College of Georgia, a 2008 Distinguished ... Alliance Eminent Scholar in Neuroscience and professor in the ... of 11 scientists to receive the award, which includes ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced that ... Administration (FDA) to market over-the-counter (OTC),Nicotine Polacrilex Gum USP, ... The FDA has determined the product to be ... mg (base) and 4 mg,(base), which is an aid ...
... April 24 Karen Ignagni,President and CEO ... issued,the following statement commending the Senate on ... Senate:, (Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO ), ... the basis of their genetic,makeup. We applaud ...
Cached Medicine News:Health News:Cystic Fibrosis Foundation Lauds Congress for Passage of Small Business Innovation Research Program 2Health News:RNC: Dems Hedge on Healthcare 2Health News:Dr. Mei honored by mental health research charity for schizophrenia studies 2Health News:Dr. Mei honored by mental health research charity for schizophrenia studies 3Health News:Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: